Cargando…

Mining FDA drug labels for medical conditions

BACKGROUND: Cincinnati Children’s Hospital Medical Center (CCHMC) has built the initial Natural Language Processing (NLP) component to extract medications with their corresponding medical conditions (Indications, Contraindications, Overdosage, and Adverse Reactions) as triples of medication-related...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qi, Deleger, Louise, Lingren, Todd, Zhai, Haijun, Kaiser, Megan, Stoutenborough, Laura, Jegga, Anil G, Cohen, Kevin Bretonnel, Solti, Imre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646673/ https://www.ncbi.nlm.nih.gov/pubmed/23617267 http://dx.doi.org/10.1186/1472-6947-13-53

Ejemplares similares

A sequence labeling approach to link medications and their attributes in clinical notes and clinical trial announcements for information extraction
por: Li, Qi, et al.
Publicado: (2013)

Web 2.0-Based Crowdsourcing for High-Quality Gold Standard Development in Clinical Natural Language Processing
por: Zhai, Haijun, et al.
Publicado: (2013)

Evaluating the impact of pre-annotation on annotation speed and potential bias: natural language processing gold standard development for clinical named entity recognition in clinical trial announcements
por: Lingren, Todd, et al.
Publicado: (2014)

Large-scale evaluation of automated clinical note de-identification and its impact on information extraction
por: Deleger, Louise, et al.
Publicado: (2013)

Phenotyping for patient safety: algorithm development for electronic health record based automated adverse event and medical error detection in neonatal intensive care
por: Li, Qi, et al.
Publicado: (2014)

Developing and evaluating an automated appendicitis risk stratification algorithm for pediatric patients in the emergency department
por: Deleger, Louise, et al.
Publicado: (2013)

Increasing the efficiency of trial-patient matching: automated clinical trial eligibility Pre-screening for pediatric oncology patients
por: Ni, Yizhao, et al.
Publicado: (2015)

An end-to-end hybrid algorithm for automated medication discrepancy detection
por: Li, Qi, et al.
Publicado: (2015)

Leveraging Food and Drug Administration Adverse Event Reports for the Automated Monitoring of Electronic Health Records in a Pediatric Hospital
por: Tang, Huaxiu, et al.
Publicado: (2017)

Automated clinical trial eligibility prescreening: increasing the efficiency of patient identification for clinical trials in the emergency department
por: Ni, Yizhao, et al.
Publicado: (2015)

A Primer to the Structure, Content and Linkage of the FDA’s Manufacturer and User Facility Device Experience (MAUDE) Files
por: Ensign, Lisa Garnsey, et al.
Publicado: (2017)

Getting Started in Text Mining
por: Cohen, K. Bretonnel, et al.
Publicado: (2008)

Integrating text mining into high-throughput assay analysis
por: Cohen, K Bretonnel
Publicado: (2010)

Mining FDA drug labels using an unsupervised learning technique - topic modeling
por: Bisgin, Halil, et al.
Publicado: (2011)

Text mining tools for extracting information about microbial biodiversity in food
por: Chaix, Estelle, et al.
Publicado: (2019)

Chapter 16: Text Mining for Translational Bioinformatics
por: Cohen, K. Bretonnel, et al.
Publicado: (2013)

Introduction to BLAH5 special issue: recent progress on interoperability of biomedical text mining
por: Kim, Jin-Dong, et al.
Publicado: (2019)

An open-source framework for large-scale, flexible evaluation of biomedical text mining systems
por: Baumgartner, William A, et al.
Publicado: (2008)

Open Agile text mining for bioinformatics: the PubAnnotation ecosystem
por: Kim, Jin-Dong, et al.
Publicado: (2019)

Understanding the new FDA pregnancy and lactation labeling rules()
por: Blattner, Collin M., et al.
Publicado: (2016)

Assessing Readability of FDA-Required Labeling for Breast Implants
por: Powell, Lauren, et al.
Publicado: (2023)

Data Mining of the Public Version of the FDA Adverse Event Reporting System
por: Sakaeda, Toshiyuki, et al.
Publicado: (2013)

Mining Human Phenome to Investigate Modularity of Complex Disorders
por: Gudivada, Ranga C, et al.
Publicado: (2008)

U-Compare: share and compare text mining tools with UIMA
por: Kano, Yoshinobu, et al.
Publicado: (2009)

Text mining and manual curation of chemical-gene-disease networks for the Comparative Toxicogenomics Database (CTD)
por: Wiegers, Thomas C, et al.
Publicado: (2009)

Pharmacogenetic Labeling of FDA-Approved Drugs: A Regulatory Retrospective
por: Drozda, Katarzyna, et al.
Publicado: (2018)

Omnicrobe, an open-access database of microbial habitats and phenotypes using a comprehensive text mining and data fusion approach
por: Dérozier, Sandra, et al.
Publicado: (2023)

EMR-linked GWAS study: investigation of variation landscape of loci for body mass index in children
por: Namjou, Bahram, et al.
Publicado: (2013)

An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation
por: Chaloupka, Frank J, et al.
Publicado: (2015)

Pharmacogenomic Biomarkers in US FDA-Approved Drug Labels (2000–2020)
por: Kim, Jeeyun A., et al.
Publicado: (2021)

Investigating drug repositioning opportunities in FDA drug labels through topic modeling
por: Bisgin, Halil, et al.
Publicado: (2012)

Characterizing the Strength of Evidence in FDA Labels for Pharmacogenomic Biomarker-Guided Medication Use
por: Chin, Lauren, et al.
Publicado: (2017)

Patient-reported outcomes in breast cancer FDA drug labels and review documents
por: Hong, Kyungwan, et al.
Publicado: (2021)

A retrospective analysis of actionable pharmacogenetic/genomic biomarker language in FDA labels
por: Yamazaki, Shinji
Publicado: (2021)

Electronic Health Record Based Algorithm to Identify Patients with Autism Spectrum Disorder
por: Lingren, Todd, et al.
Publicado: (2016)

FDA approved drugs as potential Ebola treatments
por: Ekins, Sean, et al.
Publicado: (2015)

Omeprazole- and Esomeprazole-associated Hypomagnesaemia: Data Mining of the Public Version of the FDA Adverse Event Reporting System
por: Tamura, Takao, et al.
Publicado: (2012)

A real-world disproportionality analysis of apalutamide: data mining of the FDA adverse event reporting system
por: Fang, Zhihong, et al.
Publicado: (2023)

Text mining for the biocuration workflow
por: Hirschman, Lynette, et al.
Publicado: (2012)

The next forum for unraveling FDA off-label marketing rules: State and federal legislatures
por: Sinha, Michael S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gg6mr4g9edn284id4gqnupobe7